Calton & Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-225
Closed -$4K 1356
2017
Q4
$4K Buy
+225
New +$4.35K ﹤0.01% 1299

Other funds holding DBD

Calton & Associates's DBD Position: Q1 2018 in Review

Calton & Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2018, closing a stake of 225 shares — an estimated $4K sold.

Calton & Associates first reported a position in DBD in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 246 funds tracked by Wall St. Rank hold DBD as of Q1 2018.

  • Calton & Associates reported no remaining Diebold Nixdorf Incorporated position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 225 Diebold Nixdorf Incorporated shares in Q1 2018, an estimated $4K.
  • Calton & Associates first reported a position in Diebold Nixdorf Incorporated in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Diebold Nixdorf Incorporated position peaked at $4K in Q4 2017.
  • 246 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.